Pillar Biosciences Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Pillar Biosciences's estimated annual revenue is currently $7.3M per year.
- Pillar Biosciences received $18.0M in venture funding in May 2016.
- Pillar Biosciences's estimated revenue per employee is $155,000
- Pillar Biosciences's total funding is $18M.
- Pillar Biosciences has 47 Employees.
- Pillar Biosciences grew their employee count by 2% last year.
- Pillar Biosciences currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Cell Signaling ...||$89.4M||577||N/A||N/A|
What Is Pillar Biosciences?
Pillar Biosciences aims to "Make Precision Medicine Accessible" by developing and manufacturing targeted next-generation sequencing (NGS)-based assays and software for today's high-throughput specialty NGS laboratories. Through our SLIMamp technology (a multiplex overlapping PCR chemistry) Pillar offers a streamlined, robust and economical workflow with high mapping and on-target metrics. In conjunction with the SLIMamp assay technology, Pillar Biosciences has an informatics pipeline called the Pillar Variant Analysis Toolkit (PiVAT) that is not only highly accurate, enabling somatic variant calls down to 1% allele frequency without use of Unique Identifiers (UIDs), but also fast and efficient, returning valuable sample data quickly. For higher-sensitivity applications such as cell-free DNA analyses, Pillar Biosciences has developed a dedicated assay technology for cell-free DNA that uses UID methodology, to work with the PiVAT pipeline to drive sensitivity down to 0.1%-0.2%.keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
Number of Employees
Employee Growth %
|Peter Chryssanthacopoulos||Sr. Manager, Quality Assurance and Regulatory Compliance. ISO Mgmt Representative.||Email Available|
|Geoffrey Richman||Sr. Product Manager|
|Jerry Riehl||Market Development Manager|
|Yue Ke||Principal Data Scientist / Director|
|Jamie Lim||Sr Project Manager|
|William Wright||Director of Sales|
|Sun Lim||Market Development Manager|
|Arie Henkin||Senior Manager, QA/RA and Operations|
|Dina Haines||Quality Control Manager|
Pillar Biosciences News
BOSTON, May 30, 2019 /PRNewswire/ -- Pillar Biosciences, a clinical cancer diagnostics company based near Boston, MA, announced today ...
SAN FRANCISCO, Jan. 10, 2019 /PRNewswire/ -- Pillar Biosciences, Inc., a clinical cancer diagnostics company based in Boston, MA, USA ...
... Pillar Biosciences, Medicover, and Hightech Gründerfund, Europe's leading startup investor, McDermott Will & Emery as well as Aescuvest.
Pillar Biosciences Funding
|2016-05-12||$18.0M||Undisclosed||ORI Healthcare Fund L.P||Article|